Navigation Links
Prostate Cancer Foundation Launches First Competition for Stupski Prize in Prostate Cancer Computational Oncology

SANTA MONICA, Calif., Dec. 15, 2015 /PRNewswire-USNewswire/ -- The Prostate Cancer Foundation (PCF) is proud to announce the launch of the Stupski Prize Challenge 1 today at 1pm EST. An image analysis data science challenge with a focus on large-scale cancer genomics, this crowdsourced competition aims to rapidly advance precision medicine for advanced prostate cancer patients and extend solutions to other cancers. The competition will award over $25,000 in prize money.

Register for Stupski Prize Challenge 1 and become a Topcoder Community Member at 

And Share To: Facebook | Twitter | LinkedIn

"We could not be more excited for the launch of the Stupski Prize Challenge 1 which further elevates the position of math, science and engineering in medicine," said Jonathan W. Simons, MD, president and chief executive officer of PCF. "By opening this competition to the global community of problem solvers, our odds for finding cures for genomically complex diseases like prostate cancer have never been greater."

Stupski Prize Challenge 1 will be open to the public for 16 days, closing on December 31, 2015. Prospective participants may find more information about the Challenge and register for free on Topcoder, which is hosting the competition.

The goal of Challenge 1 is to help bridge the gap between molecular "big data" and individual prostate cancer patients. One common feature of prostate tumor cells is the loss or gain of specific pieces of DNA.  The fraction of genome altered (FGA) is a measure of how the DNA of the tumor cells has changed. In the clinic, FGA can be used as a predictor of survival and can indicate which therapies are most likely to be successful in a patient.

Currently, physicians use an expensive, 2-week long genetic test to determine the FGA of prostate cancer tissue. However, many scientists believe that it is possible to determine FGA from features present in prostate tissue biopsy images. Predicting the genetic characteristics of a tumor using high resolution images of biopsies could potentially obviate the need for expensive, time-intensive genetic tests.

In order to test this hypothesis, participants will be given a test set of prostate biopsy images and asked to predict the FGA. Winners will be determined based on their scored performance as determined by a scoring metric based on the mean squared error of their predicted FGAs.

The Stupski Prize Challenge 1 marks the first competitive Stupski Prize in Computational Oncology awarded this year. The inaugural prize was presented in April to PCF Young Investigator Nikolaus Schultz, PhD, Associate Member in Computational Oncology at Memorial Sloan Kettering Cancer Center, in recognition of his work developing the cBioPortal for Cancer Genomics. Dr. Schultz is chairman for the Stupski Prize Committee.

This first-in-field initiative is named in memory of visionary philanthropist Lawrence J. Stupski, the former president and chief operating officer of Charles Schwab Corporation. To celebrate his legacy, the Stupski Foundation has provided funds for the Stupski Prize.

About the Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $634 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.

About Appirio/Topcoder

Appirio is a global cloud consultancy that helps customers achieve results in weeks, not years by harnessing the power of the world's top talent. Topcoder's 900,000+ member community and crowdsourcing platform, combined with the company's business and technical expertise, have helped 800+ enterprises confidently use technology to increase innovation and transform business. Founded in 2006, Appirio is a trusted partner to companies such as Apria, Coca-Cola, eBay, Facebook, Japan Post Network, L'Oreal, NetApp, The Four Seasons and Virgin America.

Alexandra Schwertfeger
Prostate Cancer Foundation

Video -

Photo -


SOURCE Prostate Cancer Foundation
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. New study: Diet linked to prostate cancer survival
2. With fewer PSA screenings, will more men die of prostate cancer?
3. Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine
4. SonaCare Medical Receives FDA Clearance for its Sonablate® High Intensity Focused Ultrasound Prostate Ablation Device
5. Aeterna Zentaris Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint in Men with Heavily Pretreated Castration and Taxane Resistant Prostate Cancer
6. Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize
7. September Is Prostate Cancer Awareness Month
8. 4K Score Test Now Offered at Dr. Samadis Prostate Cancer Center
9. New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadis Prostate Cancer Center
10. Prostate Cancer: Getting a Second Opinion
11. Dr. David Samadis Prostate Cancer Center Offers Biomarker Diagnostic Testing for Prostate Cancer
Post Your Comments:
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
Breaking Biology News(10 mins):